Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Insys Therapeutics Inc.

www.insysrx.com

Latest From Shire PLC

Shire Aims To Stay On Top In Hemophilia With Novimmune Pact

Having become embroiled in a legal tussle with Roche last week concerning the latter's emicizumab, Shire has licensed a hemophilia A bispecific monoclonal antibody of its own.

Blood & Coagulation Disorders Deals

Phase III Updates Bode Well For Filings Of Roche's Emicizumab In Hemophilia

Roche believes it can address thrombotic safety issues that cropped up with bispecific antibody emicizumab by providing regulators with guidance on dosing.

Research & Development Clinical Trials

Kamada's Plans For Emphysema Drug Delayed By Years After MAA Withdrawal

Kamada has withdrawn its European approval application for an inhaled version of its emphysema drug Glassia – a move that shocked investors because of the company's continued insistence data from a failed pivotal study would be enough to convince regulators.

Market Intelligence Respiratory

Keeping Track: Cardio, Antibiotic Approvals Put FDA Over Last Year's Novel Drug Count

The latest drug development news and US FDA highlights from our Performance Tracker.

Regulation Approvals
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
  • Therapeutic Areas
  • Cancer
  • Gastrointestinal
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Insys Therapeutics Inc.
  • Senior Management
  • N L Kapoor John, Pres. & CEO
    Darryl S Baker, CFO
    Larry Dillaha, MD, CMO
  • Contact Info
  • Insys Therapeutics Inc.
    Phone: (602) 910-2617
    10220 S. 51st St.
    Ste. 2
    Phoenix, AZ 85044
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register